PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

Wilsons Report 13 September

  1. Atomboi
    69 Posts.
    lightbulb Created with Sketch. 51
    clock Created with Sketch.
    13/09/22
    14:26
    Post #: 63672523
    New report from Wilsons...
    Click HERE for the report
    Valuation. Changes to trial timelines affects our real options NPVs, which reduces our risked valuation to $0.36/share, with 79% of our valuation associated with EU ATL1102 opportunity with the balance in the US market. Our revised un-risked valuation is $1.00/share.
    Last edited by Atomboi: edit link 13/09/22
    ANP Price at posting: 9.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.